 | • レポートコード：GIR-105X12928 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、経口避妊薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。経口避妊薬の種類別市場規模（長時間作用型避妊薬、短時間作用型避妊薬、緊急避妊薬）、用途別市場規模（病院、薬局、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・経口避妊薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Bayer、Pfizer、Teva Pharmaceutical、Merck、Actavis、Johnson & Johnson、Gedeon Richter、Novo Nordisk A/S、ZiZhu、Baijingyu、Huazhong ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：長時間作用型避妊薬、短時間作用型避妊薬、緊急避妊薬 ・用途別分析2016年-2026年：病院、薬局、その他 ・経口避妊薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・経口避妊薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・経口避妊薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・経口避妊薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・経口避妊薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Oral Contraceptive Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Oral Contraceptive Drugs size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Oral Contraceptive Drugs market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Oral Contraceptive Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Long-acting Contraceptives
Short-acting Contraceptives
Emergency Contraceptives
Market segment by Application can be divided into
Hospital
Pharmacy
Other
The key market players for global Oral Contraceptive Drugs market are listed below:
Bayer
Pfizer
Teva Pharmaceutical
Merck
Actavis
Johnson & Johnson
Gedeon Richter
Novo Nordisk A/S
ZiZhu
Baijingyu
Huazhong
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Oral Contraceptive Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Oral Contraceptive Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Long-acting Contraceptives
1.2.3 Short-acting Contraceptives
1.2.4 Emergency Contraceptives
1.3 Market Analysis by Application
1.3.1 Overview: Global Oral Contraceptive Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Global Oral Contraceptive Drugs Market Size & Forecast
1.4.1 Global Oral Contraceptive Drugs Sales in Value (2016-2026))
1.4.2 Global Oral Contraceptive Drugs Sales in Volume (2016-2026)
1.4.3 Global Oral Contraceptive Drugs Price by Type (2016-2026) & (K MT)
1.5 Global Oral Contraceptive Drugs Production Capacity Analysis
1.5.1 Global Oral Contraceptive Drugs Total Production Capacity (2016-2026)
1.5.2 Global Oral Contraceptive Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Oral Contraceptive Drugs Market Drivers
1.6.2 Oral Contraceptive Drugs Market Restraints
1.6.3 Oral Contraceptive Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Bayer Details
2.1.2 Bayer Major Business
2.1.3 Bayer Oral Contraceptive Drugs Product and Services
2.1.4 Bayer Oral Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Oral Contraceptive Drugs Product and Services
2.2.4 Pfizer Oral Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Teva Pharmaceutical
2.3.1 Teva Pharmaceutical Details
2.3.2 Teva Pharmaceutical Major Business
2.3.3 Teva Pharmaceutical Oral Contraceptive Drugs Product and Services
2.3.4 Teva Pharmaceutical Oral Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck Oral Contraceptive Drugs Product and Services
2.4.4 Merck Oral Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Actavis
2.5.1 Actavis Details
2.5.2 Actavis Major Business
2.5.3 Actavis Oral Contraceptive Drugs Product and Services
2.5.4 Actavis Oral Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business
2.6.3 Johnson & Johnson Oral Contraceptive Drugs Product and Services
2.6.4 Johnson & Johnson Oral Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Gedeon Richter
2.7.1 Gedeon Richter Details
2.7.2 Gedeon Richter Major Business
2.7.3 Gedeon Richter Oral Contraceptive Drugs Product and Services
2.7.4 Gedeon Richter Oral Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Novo Nordisk A/S
2.8.1 Novo Nordisk A/S Details
2.8.2 Novo Nordisk A/S Major Business
2.8.3 Novo Nordisk A/S Oral Contraceptive Drugs Product and Services
2.8.4 Novo Nordisk A/S Oral Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 ZiZhu
2.9.1 ZiZhu Details
2.9.2 ZiZhu Major Business
2.9.3 ZiZhu Oral Contraceptive Drugs Product and Services
2.9.4 ZiZhu Oral Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Baijingyu
2.10.1 Baijingyu Details
2.10.2 Baijingyu Major Business
2.10.3 Baijingyu Oral Contraceptive Drugs Product and Services
2.10.4 Baijingyu Oral Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Huazhong
2.11.1 Huazhong Details
2.11.2 Huazhong Major Business
2.11.3 Huazhong Oral Contraceptive Drugs Product and Services
2.11.4 Huazhong Oral Contraceptive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Oral Contraceptive Drugs Sales by Manufacturer
3.1 Global Oral Contraceptive Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Oral Contraceptive Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Oral Contraceptive Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Oral Contraceptive Drugs Manufacturer Market Share
3.4.2 Top 6 Oral Contraceptive Drugs Manufacturer Market Share
3.5 Global Oral Contraceptive Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Oral Contraceptive Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Oral Contraceptive Drugs Market Size by Region
4.1.1 Global Oral Contraceptive Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Oral Contraceptive Drugs Revenue by Region (2016-2026)
4.2 North America Oral Contraceptive Drugs Revenue (2016-2026)
4.3 Europe Oral Contraceptive Drugs Revenue (2016-2026)
4.4 Asia-Pacific Oral Contraceptive Drugs Revenue (2016-2026)
4.5 South America Oral Contraceptive Drugs Revenue (2016-2026)
4.6 Middle East and Africa Oral Contraceptive Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Oral Contraceptive Drugs Sales in Volume by Type (2016-2026)
5.2 Global Oral Contraceptive Drugs Revenue by Type (2016-2026)
5.3 Global Oral Contraceptive Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Oral Contraceptive Drugs Sales in Volume by Application (2016-2026)
6.2 Global Oral Contraceptive Drugs Revenue by Application (2016-2026)
6.3 Global Oral Contraceptive Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Oral Contraceptive Drugs Sales by Type (2016-2026)
7.2 North America Oral Contraceptive Drugs Sales by Application (2016-2026)
7.3 North America Oral Contraceptive Drugs Market Size by Country
7.3.1 North America Oral Contraceptive Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Oral Contraceptive Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Oral Contraceptive Drugs Sales by Type (2016-2026)
8.2 Europe Oral Contraceptive Drugs Sales by Application (2016-2026)
8.3 Europe Oral Contraceptive Drugs Market Size by Country
8.3.1 Europe Oral Contraceptive Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Oral Contraceptive Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Oral Contraceptive Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Oral Contraceptive Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Oral Contraceptive Drugs Market Size by Region
9.3.1 Asia-Pacific Oral Contraceptive Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Oral Contraceptive Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Oral Contraceptive Drugs Sales by Type (2016-2026)
10.2 South America Oral Contraceptive Drugs Sales by Application (2016-2026)
10.3 South America Oral Contraceptive Drugs Market Size by Country
10.3.1 South America Oral Contraceptive Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Oral Contraceptive Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Oral Contraceptive Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Oral Contraceptive Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Oral Contraceptive Drugs Market Size by Country
11.3.1 Middle East & Africa Oral Contraceptive Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Oral Contraceptive Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Oral Contraceptive Drugs Typical Distributors
12.3 Oral Contraceptive Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Oral Contraceptive Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Oral Contraceptive Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Bayer Basic Information, Manufacturing Base and Competitors
Table 4. Bayer Major Business
Table 5. Bayer Oral Contraceptive Drugs Product and Services
Table 6. Bayer Oral Contraceptive Drugs Sales (K MT), Price (K MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Major Business
Table 9. Pfizer Oral Contraceptive Drugs Product and Services
Table 10. Pfizer Oral Contraceptive Drugs Sales (K MT), Price (K MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 12. Teva Pharmaceutical Major Business
Table 13. Teva Pharmaceutical Oral Contraceptive Drugs Product and Services
Table 14. Teva Pharmaceutical Oral Contraceptive Drugs Sales (K MT), Price (K MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Merck Basic Information, Manufacturing Base and Competitors
Table 16. Merck Major Business
Table 17. Merck Oral Contraceptive Drugs Product and Services
Table 18. Merck Oral Contraceptive Drugs Sales (K MT), Price (K MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Actavis Basic Information, Manufacturing Base and Competitors
Table 20. Actavis Major Business
Table 21. Actavis Oral Contraceptive Drugs Product and Services
Table 22. Actavis Oral Contraceptive Drugs Sales (K MT), Price (K MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 24. Johnson & Johnson Major Business
Table 25. Johnson & Johnson Oral Contraceptive Drugs Product and Services
Table 26. Johnson & Johnson Oral Contraceptive Drugs Sales (K MT), Price (K MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Gedeon Richter Basic Information, Manufacturing Base and Competitors
Table 28. Gedeon Richter Major Business
Table 29. Gedeon Richter Oral Contraceptive Drugs Product and Services
Table 30. Gedeon Richter Oral Contraceptive Drugs Sales (K MT), Price (K MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Novo Nordisk A/S Basic Information, Manufacturing Base and Competitors
Table 32. Novo Nordisk A/S Major Business
Table 33. Novo Nordisk A/S Oral Contraceptive Drugs Product and Services
Table 34. Novo Nordisk A/S Oral Contraceptive Drugs Sales (K MT), Price (K MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. ZiZhu Basic Information, Manufacturing Base and Competitors
Table 36. ZiZhu Major Business
Table 37. ZiZhu Oral Contraceptive Drugs Product and Services
Table 38. ZiZhu Oral Contraceptive Drugs Sales (K MT), Price (K MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Baijingyu Basic Information, Manufacturing Base and Competitors
Table 40. Baijingyu Major Business
Table 41. Baijingyu Oral Contraceptive Drugs Product and Services
Table 42. Baijingyu Oral Contraceptive Drugs Sales (K MT), Price (K MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Huazhong Basic Information, Manufacturing Base and Competitors
Table 44. Huazhong Major Business
Table 45. Huazhong Oral Contraceptive Drugs Product and Services
Table 46. Huazhong Oral Contraceptive Drugs Sales (K MT), Price (K MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Global Oral Contraceptive Drugs Sales by Manufacturer (2019-2021e) & (K MT)
Table 48. Global Oral Contraceptive Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 49. Market Position of Manufacturers in Oral Contraceptive Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 50. Global Oral Contraceptive Drugs Production Capacity by Company, (K MT): 2020 VS 2021
Table 51. Head Office and Oral Contraceptive Drugs Production Site of Key Manufacturer
Table 52. Global Oral Contraceptive Drugs Sales by Region (2016-2021e) & (K MT)
Table 53. Global Oral Contraceptive Drugs Sales by Region (2021-2026) & (K MT)
Table 54. Global Oral Contraceptive Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 55. Global Oral Contraceptive Drugs Revenue by Region (2021-2026) & (USD Million)
Table 56. Global Oral Contraceptive Drugs Sales by Type (2016-2021e) & (K MT)
Table 57. Global Oral Contraceptive Drugs Sales by Type (2021-2026) & (K MT)
Table 58. Global Oral Contraceptive Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 59. Global Oral Contraceptive Drugs Revenue by Type (2021-2026) & (USD Million)
Table 60. Global Oral Contraceptive Drugs Price by Type (2016-2021e) & (K MT)
Table 61. Global Oral Contraceptive Drugs Price by Type (2021-2026) & (K MT)
Table 62. Global Oral Contraceptive Drugs Sales by Application (2016-2021e) & (K MT)
Table 63. Global Oral Contraceptive Drugs Sales by Application (2021-2026) & (K MT)
Table 64. Global Oral Contraceptive Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 65. Global Oral Contraceptive Drugs Revenue by Application (2021-2026) & (USD Million)
Table 66. Global Oral Contraceptive Drugs Price by Application (2016-2021e) & (K MT)
Table 67. Global Oral Contraceptive Drugs Price by Application (2021-2026) & (K MT)
Table 68. North America Oral Contraceptive Drugs Sales by Country (2016-2021e) & (K MT)
Table 69. North America Oral Contraceptive Drugs Sales by Country (2021-2026) & (K MT)
Table 70. North America Oral Contraceptive Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 71. North America Oral Contraceptive Drugs Revenue by Country (2021-2026) & (USD Million)
Table 72. North America Oral Contraceptive Drugs Sales by Type (2016-2021e) & (K MT)
Table 73. North America Oral Contraceptive Drugs Sales by Type (2021-2026) & (K MT)
Table 74. North America Oral Contraceptive Drugs Sales by Application (2016-2021e) & (K MT)
Table 75. North America Oral Contraceptive Drugs Sales by Application (2021-2026) & (K MT)
Table 76. Europe Oral Contraceptive Drugs Sales by Country (2016-2021e) & (K MT)
Table 77. Europe Oral Contraceptive Drugs Sales by Country (2021-2026) & (K MT)
Table 78. Europe Oral Contraceptive Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 79. Europe Oral Contraceptive Drugs Revenue by Country (2021-2026) & (USD Million)
Table 80. Europe Oral Contraceptive Drugs Sales by Type (2016-2021e) & (K MT)
Table 81. Europe Oral Contraceptive Drugs Sales by Type (2021-2026) & (K MT)
Table 82. Europe Oral Contraceptive Drugs Sales by Application (2016-2021e) & (K MT)
Table 83. Europe Oral Contraceptive Drugs Sales by Application (2021-2026) & (K MT)
Table 84. Asia-Pacific Oral Contraceptive Drugs Sales by Region (2016-2021e) & (K MT)
Table 85. Asia-Pacific Oral Contraceptive Drugs Sales by Region (2021-2026) & (K MT)
Table 86. Asia-Pacific Oral Contraceptive Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 87. Asia-Pacific Oral Contraceptive Drugs Revenue by Region (2021-2026) & (USD Million)
Table 88. Asia-Pacific Oral Contraceptive Drugs Sales by Type (2016-2021e) & (K MT)
Table 89. Asia-Pacific Oral Contraceptive Drugs Sales by Type (2021-2026) & (K MT)
Table 90. Asia-Pacific Oral Contraceptive Drugs Sales by Application (2016-2021e) & (K MT)
Table 91. Asia-Pacific Oral Contraceptive Drugs Sales by Application (2021-2026) & (K MT)
Table 92. South America Oral Contraceptive Drugs Sales by Country (2016-2021e) & (K MT)
Table 93. South America Oral Contraceptive Drugs Sales by Country (2021-2026) & (K MT)
Table 94. South America Oral Contraceptive Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 95. South America Oral Contraceptive Drugs Revenue by Country (2021-2026) & (USD Million)
Table 96. South America Oral Contraceptive Drugs Sales by Type (2016-2021e) & (K MT)
Table 97. South America Oral Contraceptive Drugs Sales by Type (2021-2026) & (K MT)
Table 98. South America Oral Contraceptive Drugs Sales by Application (2016-2021e) & (K MT)
Table 99. South America Oral Contraceptive Drugs Sales by Application (2021-2026) & (K MT)
Table 100. Middle East & Africa Oral Contraceptive Drugs Sales by Country (2016-2021e) & (K MT)
Table 101. Middle East & Africa Oral Contraceptive Drugs Sales by Country (2021-2026) & (K MT)
Table 102. Middle East & Africa Oral Contraceptive Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 103. Middle East & Africa Oral Contraceptive Drugs Revenue by Country (2021-2026) & (USD Million)
Table 104. Middle East & Africa Oral Contraceptive Drugs Sales by Type (2016-2021e) & (K MT)
Table 105. Middle East & Africa Oral Contraceptive Drugs Sales by Type (2021-2026) & (K MT)
Table 106. Middle East & Africa Oral Contraceptive Drugs Sales by Application (2016-2021e) & (K MT)
Table 107. Middle East & Africa Oral Contraceptive Drugs Sales by Application (2021-2026) & (K MT)
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Oral Contraceptive Drugs Typical Distributors
Table 111. Oral Contraceptive Drugs Typical Customers
List of Figures
Figure 1. Oral Contraceptive Drugs Picture
Figure 2. Global Oral Contraceptive Drugs Sales Market Share by Type in 2020
Figure 3. Long-acting Contraceptives
Figure 4. Short-acting Contraceptives
Figure 5. Emergency Contraceptives
Figure 6. Global Oral Contraceptive Drugs Sales Market Share by Application in 2020
Figure 7. Hospital
Figure 8. Pharmacy
Figure 9. Other
Figure 10. Global Oral Contraceptive Drugs Market Size, (USD Million) & (K MT): 2020 VS 2021 VS 2026
Figure 11. Global Oral Contraceptive Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. United States Oral Contraceptive Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Canada Oral Contraceptive Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Mexico Oral Contraceptive Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Germany Oral Contraceptive Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. France Oral Contraceptive Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. United Kingdom Oral Contraceptive Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Russia Oral Contraceptive Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Italy Oral Contraceptive Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. China Oral Contraceptive Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Japan Oral Contraceptive Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Korea Oral Contraceptive Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. India Oral Contraceptive Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Southeast Asia Oral Contraceptive Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Australia Oral Contraceptive Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Brazil Oral Contraceptive Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Egypt Oral Contraceptive Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Saudi Arabia Oral Contraceptive Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. South Africa Oral Contraceptive Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Turkey Oral Contraceptive Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Global Oral Contraceptive Drugs Sales (2016-2026) & (K MT)
Figure 32. Global Oral Contraceptive Drugs Production Capacity (2016-2026) & (K MT)
Figure 33. Global Oral Contraceptive Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 34. Oral Contraceptive Drugs Market Drivers
Figure 35. Oral Contraceptive Drugs Market Restraints
Figure 36. Oral Contraceptive Drugs Market Trends
Figure 37. Global Oral Contraceptive Drugs Sales Market Share by Manufacturer in 2020
Figure 38. Global Oral Contraceptive Drugs Revenue Market Share by Manufacturer in 2020
Figure 39. Oral Contraceptive Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 40. Top 3 Oral Contraceptive Drugs Manufacturer (Revenue) Market Share in 2020
Figure 41. Top 6 Oral Contraceptive Drugs Manufacturer (Revenue) Market Share in 2020
Figure 42. Global Oral Contraceptive Drugs Sales Market Share by Region (2016-2026)
Figure 43. Global Oral Contraceptive Drugs Revenue Market Share by Region (2016-2026)
Figure 44. North America Oral Contraceptive Drugs Revenue (2016-2026) & (USD Million)
Figure 45. Europe Oral Contraceptive Drugs Revenue (2016-2026) & (USD Million)
Figure 46. Asia-Pacific Oral Contraceptive Drugs Revenue (2016-2026) & (USD Million)
Figure 47. South America Oral Contraceptive Drugs Revenue (2016-2026) & (USD Million)
Figure 48. Middle East & Africa Oral Contraceptive Drugs Revenue (2016-2026) & (USD Million)
Figure 49. Global Oral Contraceptive Drugs Sales Market Share by Type (2016-2026)
Figure 50. Global Oral Contraceptive Drugs Revenue Market Share by Type (2016-2026)
Figure 51. Global Oral Contraceptive Drugs Price by Type (2016-2026) & (K MT)
Figure 52. Global Oral Contraceptive Drugs Sales Market Share by Application (2016-2026)
Figure 53. Global Oral Contraceptive Drugs Revenue Market Share by Application (2016-2026)
Figure 54. Global Oral Contraceptive Drugs Price by Application (2016-2026) & (K MT)
Figure 55. North America Oral Contraceptive Drugs Sales Market Share by Country (2016-2026)
Figure 56. North America Oral Contraceptive Drugs Revenue Market Share by Country (2016-2026)
Figure 57. North America Oral Contraceptive Drugs Sales Market Share by Type (2016-2026)
Figure 58. North America Oral Contraceptive Drugs Sales Market Share by Application (2016-2026)
Figure 59. Europe Oral Contraceptive Drugs Sales Market Share by Country (2016-2026)
Figure 60. Europe Oral Contraceptive Drugs Revenue Market Share by Country (2016-2026)
Figure 61. Europe Oral Contraceptive Drugs Sales Market Share by Type (2016-2026)
Figure 62. Europe Oral Contraceptive Drugs Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Oral Contraceptive Drugs Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Oral Contraceptive Drugs Revenue Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Oral Contraceptive Drugs Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Oral Contraceptive Drugs Sales Market Share by Application (2016-2026)
Figure 67. South America Oral Contraceptive Drugs Sales Market Share by Country (2016-2026)
Figure 68. South America Oral Contraceptive Drugs Revenue Market Share by Country (2016-2026)
Figure 69. South America Oral Contraceptive Drugs Sales Market Share by Type (2016-2026)
Figure 70. South America Oral Contraceptive Drugs Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Oral Contraceptive Drugs Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Oral Contraceptive Drugs Revenue Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Oral Contraceptive Drugs Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Oral Contraceptive Drugs Sales Market Share by Application (2016-2026)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
世界の避妊薬市場 2021：企業別、地域別、種類・用途別 The Contraceptives Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulation…- 避妊薬薬・デバイスの世界市場2018-2025 A contraceptive is a device or drug that prevents a woman from becoming pregnant.The key factors contributing to the contraceptive drugs and devices market are growing prevalence of sexually transmitted diseases and the growing need to control the rising population. In 2018, the global Contraceptive…
- メルカプトプリン経口液剤の世界市場2018-2025 Mercaptopurine, a nucleoside metabolic inhibitor, known chemically as 1,7-dihydro-6H-purine-6-thione monohydrate, is an analogue of the purine bases adenine and hypoxanthine. In 2018, the global Mercaptopurine Oral Solution Drugs market size was xx million US$ and is forecast to xx million US in 202…
- メトトレキサート薬口径薬の世界市場2018-2025 Methotrexate (MTX), formerly known as amethopterin, is a chemotherapy agent and immune system suppressant.[1] It is used to treat cancer, autoimmune diseases, ectopic pregnancy, and for medical abortions.In 2018, the global Methotrexate Oral Solution Drugs market size was xx million US$ and is forec…
- 世界の新規経口抗凝固薬市場 2021：企業別、地域別、種類・用途別 The Novel Oral Anticoagulants Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…